BRCA1 and neoplasm: We determined tumor cell proliferation in vivo and observed that the percentages of Ki-67-positive cells were comparable in p18−/− and p18−/−; Brca1+/− or p18−/−; Gata3+/− tumors (Fig. 1d, Additional file 1: Fig. S1).